Beneficios Do Jejum - Brad Pilon

[planeta 5553]

http://www.caam.rice.edu/~cox/wrap/norepinephrine.pdf

[planeta 5553]

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3946160/

 

Fasting: Molecular Mechanisms and Clinical Applications

Valter D. Longo¹ and Mark P. Mattson^2,3

Author information ► Copyright and License information ►

 

The publisher's final edited version of this article is available at Cell Metab

See other articles in PMC that cite the published article.

 

Go to:

Abstract

Fasting has been practiced for millennia, but only recently studies have shed light on its role in adaptive cellular responses that reduce oxidative damage and inflammation, optimize energy metabolism and bolster cellular protection. In lower eukaryotes, chronic fasting extends longevity in part by reprogramming metabolic and stress resistance pathways. In rodents intermittent or periodic fasting protects against diabetes, cancers, heart disease and neurodegeneration, while in humans it helps reduce obesity, hypertension, asthma and rheumatoid arthritis. Thus, fasting has the potential to delay aging and help prevent and treat diseases while minimizing the side effects caused by chronic dietary interventions.

Introduction

In humans, fasting is achieved by ingesting no or minimal amounts of food and caloric beverages for periods that typically range from 12 hours to three weeks. Many religious groups incorporate periods of fasting into their rituals including Muslims who fast from dawn until dusk during the month of Ramadan, and Christians, Jews, Buddhists and Hindus who traditionally fast on designated days of the week or calendar year. In many clinics, patients are now monitored by physicians while undergoing water only or very low calorie (less than 200 kcal/day) fasting periods lasting from 1 week or longer for weight management, and for disease prevention and treatment. Fasting is distinct from caloric restriction (CR) in which the daily caloric intake is reduced chronically by 20–40%, but meal frequency is maintained. Starvation is instead a chronic nutritional insufficiency that is commonly used as a substitute for the word fasting, particularly in lower eukaryotes, but that is also used to define extreme forms of fasting, which can result in degeneration and death. We now know that fasting results in ketogenesis, promotes potent changes in metabolic pathways and cellular processes such as stress resistance, lipolysis and autophagy, and can have medical applications that in some cases are as effective as those of approved drugs such as the dampening of seizures and seizure-associated brain damage and the amelioration of rheumatoid arthritis (Bruce-Keller et al., 1999; Hartman et al., 2012;Muller et al., 2001). As detailed in the remainder of this article, findings from well-controlled investigations in experimental animals, and emerging findings from human studies, indicate that different forms of fasting may provide effective strategies to reduce weight, delay aging, and optimize health. Here we review the fascinating and potent effects of different forms of fasting including intermittent fasting (IF, including alternate day fasting, or twice weekly fasting, for example) and periodic fasting (PF) lasting several days or longer every 2 or more weeks. We focus on fasting and minimize the discussion of CR, a topic reviewed elsewhere (Fontana et al., 2010; Masoro, 2005).

Lessons from simple organisms

The remarkable effects of the typical 20–40% CR on aging and diseases in mice and rats are often viewed as responses evolved in mammals to adapt to periods of limited availability of food (Fontana and Klein, 2007;Fontana et al., 2010; Masoro, 2005; Weindruch and Walford, 1988). However, the cellular and molecular mechanisms responsible for the protective effects of CR have likely evolved billions of years earlier in prokaryotes attempting to survive in an environment largely or completely devoid of energy sources while avoiding age-dependent damage that could compromise fitness. In fact, E. coli switched from a nutrient rich broth to a calorie-free medium survive 4 times longer, an effect reversed by the addition of various nutrients but not acetate, a carbon source associated with starvation conditions (Figure 1A) (Gonidakis et al., 2010). The effect of rich medium but not acetate in reducing longevity raises the possibility that a ketone body-like carbon source such as acetate may be part of an “alternate metabolic program” that evolved billions of years ago in microorganisms and that now allows mammals to survive during periods of food deprivation by obtaining much of the energy by catabolizing fatty acids and ketone bodies including acetoacetate and β-hydroxybutyrate (Cahill, 2006).

Figure 1

Fasting extends lifespans of yeast, worms and mice

In the yeast S. cerevisiae, switching cells from standard growth medium to water also causes a consistent 2-fold chronological lifespan extension as well as a major increase in the resistance to multiple stresses (Figure 1B) (Longo et al., 1997; Longo et al., 2012). The mechanisms of food deprivation-dependent lifespan extension involve the down-regulation of the amino acid response Tor-S6K (Sch9) pathway as well as of the glucose responsive Ras-adenylate cyclase-PKA pathway resulting in the activation of the serine/threonine kinase Rim15, a key enzyme coordinating the protective responses (Fontana et al., 2010). The inactivation of Tor-S6K, Ras-AC-PKA and activation of Rim15 result in increased transcription of genes including superoxide dismutases and heat shock proteins controlled by stress responsive transcription factors Msn2, Msn4 and Gis1, required for the majority of the protective effects caused by food deprivation (Wei et al., 2008). Notably, when switched to food deprivation conditions, both bacteria and yeast enter a hypometabolic mode that allows them to minimize the use of reserve carbon sources and can also accumulate high levels of the ketone body-like acetic acid, analogously to mammals.

Another major model organism in which fasting extends lifespan is the nematode C. elegans. Food deprivation conditions achieved by feeding worms little or no bacteria, lead to a major increase in lifespan (Figure 1C) (Kaeberlein et al., 2006; Lee et al., 2006), which requires AMPK as well as the stress resistance transcription factor DAF-16, similarly to the role of transcription factors Msn2/4 and Gis1 in yeast and FOXOs in flies and mammals (Greer et al., 2007). Intermittent food deprivation also extends lifespan in C. elegans by a mechanism involving the small GTPase RHEB-1 (Honjoh et al., 2009).

In flies, most studies indicate that intermittent food deprivation does not affect lifespan (Grandison et al., 2009). However, food reduction or food dilution have been consistently shown to extend Drosophilalongevity (Piper and Partridge, 2007) suggesting that flies can benefit from dietary restriction but may be sensitive to even short starvation periods.

Together these results indicate that food deprivation can result in pro-longevity effects in a wide variety of organisms, but also underline that different organisms have different responses to fasting.

Adaptive responses to fasting in mammals

In most mammals, the liver serves as the main reservoir of glucose, which is stored in the form of glycogen. In humans, depending upon their level of physical activity, 12 to 24 hours of fasting typically results in a 20% or greater decrease in serum glucose and depletion of the hepatic glycogen, accompanied by a switch to a metabolic mode in which non-hepatic glucose, fat-derived ketone bodies and free fatty acids are used as energy sources (Figures 2 and and3).3). Whereas most tissues can utilize fatty acids for energy, during prolonged periods of fasting, the brain relies on the ketone bodies β-hydroxybutyrate and acetoacetate in addition to glucose for energy consumption (Figure 3B). Ketone bodies are produced in hepatocytes from the acetyl-CoA generated from β oxidation of fatty acids released into the bloodstream by adipocytes, and also by the conversion of ketogenic amino acids. After hepatic glycogen depletion, ketone bodies, fat-derived glycerol, and amino acids account for the gluconeogenesis-dependent generation of approximately 80 grams/day of glucose, which is mostly utilized by the brain. Depending on body weight and composition, the ketone bodies, free fatty acids and gluconeogenesis allow the majority of human beings to survive 30 or more days in the absence of any food and allow certain species, such as king penguins, to survive for over 5 months without food (Eichhorn et al., 2011) (Figure 3C). In humans, during prolonged fasting, the plasma levels of 3-β-hydroxybutyrate are about 5 times those of free fatty acids and acetoacetic acid (Figure 3A and 3B). The brain and other organs utilize ketone bodies in a process termed ketolysis, in which acetoacetic acid and 3-β-hydroxybutyrate are converted into acetoacetyl-CoA and then acetyl-CoA. These metabolic adaptations to fasting in mammals are reminiscent of those described earlier for E. coli and yeast, in which acetic acid accumulates in response to food deprivation (Gonidakis et al., 2010; Longo et al., 2012). In yeast, glucose, acetic acid and ethanol, but not glycerol which is also generated during fasting from the breakdown of fats, accelerate aging (Fabrizio et al., 2005; Wei et al., 2009). Thus, glycerol functions as a carbon source that does not activate the pro-aging nutrient signaling pathways but can be catabolized by cells. It will be important to understand how the different carbon sources generated during fasting affect cellular protection and aging. and to determine whether glycerol, specific ketone bodies or fatty acids can provide nourishment while reducing cellular aging in mammals, a possibility suggested by beneficial effects of a dietary ketone precursor in a mouse model of Alzheimer’s disease (Kashiwaya et al., 2012). It will also be important to study, in various model organisms and humans, how high intake of specific types of fats (medium- vs. long-chain fatty acids, etc.) in substitution of carbohydrates and proteins influences gluconeogenesis and glucose levels as well as aging and diseases.

Figure 2

Pivotal roles of the nervous and endocrine systems as mediators of adaptive responses of major organ systems to intermittent fasting

Figure 3

Fasting in mammals

Fasting and the brain

In mammals, severe CR/food deprivation results in a decrease in the size of most organs except the brain, and the testicles in male mice (Weindruch and Sohal, 1997). From an evolutionary perspective this implies that maintenance of a high level of cognitive function under conditions of food scarcity is of preeminent importance. Indeed, a highly conserved behavioral trait of all mammals is to be active when hungry and sedentary when satiated. In rodents, alternating days of normal feeding and fasting (IF) can enhance brain function as indicated by improvements in performance on behavioral tests of sensory and motor function (Singh et al., 2012) and learning and memory (Fontan-Lozano et al., 2007). The behavioral responses to IF are associated with increased synaptic plasticity and increased production of new neurons from neural stem cells (Lee et al., 2002).

Particularly interesting with regards to adaptive responses of the brain to limited food availability during human evolution is brain-derived neurotrophic factor (BDNF). The genes encoding BDNF and its receptor TrkB appeared in genomes relatively recently as they are present in vertebrates, but absent from worms, flies and lower species (Chao, 2000). The prominent roles of BDNF in the regulation of energy intake and expenditure in mammals is highlighted by the fact that the receptors for both BDNF and insulin are coupled to the highly conserved PI3 kinase – Akt, and MAP kinase signaling pathways (Figure 4). Studies of rats and mice have shown that running wheel exercise and IF increase BDNF expression in several regions of the brain, and that BDNF in part mediates exercise- and IF-induced enhancement of synaptic plasticity, neurogenesis and neuronal resistance to injury and disease (see sections on fasting and neurodegeneration below). BDNF signaling in the brain may also mediate behavioral and metabolic responses to fasting and exercise including regulation of appetite, activity levels, peripheral glucose metabolism and autonomic control of the cardiovascular and gastrointestinal systems (Mattson, 2012a, b; Rothman et al., 2012).

Figure 4

Neural circuits and cellular signaling pathways the mediate adaptive responses of the brain to fasting

Hunger is an adaptive response to food deprivation that involves sensory, cognitive and neuroendocrine changes which motivate and enable food seeking behaviors. It has been proposed that hunger-related neuronal networks, neuropeptides and hormones play pivotal roles in the beneficial effects of energy restriction on aging and disease susceptibility. As evidence, when mice in which the hypothalamic ‘hunger peptide’ NPY is selectively ablated are maintained on a CR diet, the ability of CR to suppress tumor growth is abolished (Shi et al., 2012). The latter study further showed that the ability of CR to elevate circulating adiponectin levels was also compromised in NPY-deficient mice, suggesting a key role for the central hunger response in peripheral endocrine adaptations to energy restriction. Adiponectin levels increase dramatically in response to fasting; and data suggest roles for adiponectin in the beneficial effects of IF on the cardiovascular system (Wan et al., 2010). The hunger response may also improve immune function during aging as ghrelin-deficient mice exhibit accelerated thymic involution during aging, and treatment of middle age mice with ghrelin increases thymocyte numbers and improves the functional diversity of peripheral T cell subsets (Peng et al., 2012). In addition to its actions on the hypothalamus and peripheral endocrine cells, fasting may increase neuronal network activity in brain regions involved in cognition, resulting in the production of BDNF, enhanced synaptic plasticity and improved stress tolerance (Rothman et al., 2012). Thus, hunger may be a critical factor involved in widespread central and peripheral adaptive responses to the challenge of food deprivation for extended time periods.

Go to:

Fasting, aging, and disease in rodent models

Different fasting methods and aging

The major differences between IF and PF in mice are the length and the frequency of the fast cycles. IF cycles usually last 24 hours and are one to a few days apart, whereas PF cycles last 2 or more days and are at least 1 week apart, which is necessary for mice to regain their normal weight. One difference in the molecular changes caused by different fasting regimes is the effect on a variety of growth factors and metabolic markers, with IF causing more frequent but less pronounced changes than PF. It will be important to determine how the frequency of specific changes such as the lowering of IGF-1 and glucose affect cellular protection, diseases and longevity. The most extensively investigated IF method in animal studies of aging has been alternate day fasting (food is withdrawn for 24 hours on alternate days, with water provided ad libitum) (Varady and Hellerstein, 2007). The magnitude of the effects of alternate day fasting on longevity in rodents depends upon the species and age at regimen initiation, and can range from a negative effect to as much as an 80% lifespan extension (Arum et al., 2009; Goodrick et al., 1990). IF every other day extended the lifespan of rats more than fasting every 3^rd or 4^th day (Carlson and Hoelzel, 1946). Fasting for 24 hours twice weekly throughout adult life resulted in a significant increase in lifespan of black-hooded rats (Kendrick, 1973). In rats, the combination of alternate day fasting and treadmill exercise resulted in greater maintenance of muscle mass than did IF or exercise alone (Sakamoto and Grunewald, 1987). Interestingly, when rats were maintained for 10 weeks on a PF diet in which they fasted 3 consecutive days each week, they were less prone to hypoglycemia during 2 hours of strenuous swimming exercise as a result of their accumulation of larger intramuscular stores of glycogen and triglycerides (Favier and Koubi, 1988). Several major physiological responses to fasting are similar to those caused by regular aerobic exercise including increased insulin sensitivity and cellular stress resistance, reduced resting blood pressure and heart rate, and increased heart rate variability as a result of increased parasympathetic tone (Figure 2) (Anson et al., 2003;Mager et al., 2006; Wan et al., 2003). Emerging findings suggest that exercise and IF retard aging and some age-related diseases by shared mechanisms involving improved cellular stress adaptation (Stranahan and Mattson, 2012). However, in two different mouse genetic backgrounds, IF did not extend mean lifespan and even reduced lifespan when initiated at 10 months (Goodrick et al., 1990). When initiated at 1.5 months, IF either increased longevity or had no effect (Figure 1D) (Goodrick et al., 1990). These results in rodents point to conserved effects of fasting on lifespan, but also to the need for a much better understanding of the type of fasting that can maximize its longevity effects and the mechanisms responsible for the detrimental effects that may be counterbalancing its anti-aging effects. For example, one possibility is that fasting may be consistently protective in young and middle aged laboratory rodents that are either gaining or maintaining a body weight, but may be detrimental in older animals that, similarly to humans, begin to lose weight prior to their death. Notably, whereas bacteria, yeast and humans can survive for several weeks or more without nutrients, most strains of mice are unable to survive more than 3 days without food. The age-dependent weight loss may make this sensitivity to long periods of fasting worse.

Fasting and cancer

Fasting can have positive effects in cancer prevention and treatment. In mice, alternate day fasting caused a major reduction in the incidence of lymphomas (Descamps et al., 2005) and fasting for 1 day per week delayed spontaneous tumorigenesis in p53-deficient mice (Berrigan et al., 2002). However, the major decrease in glucose, insulin and IGF-1 caused by fasting, which is accompanied by cell death and/or atrophy in a wide range of tissues and organs including the liver and kidneys, is followed by a period of abnormally high cellular proliferation in these tissues driven in part by the replenishment of growth factors during refeeding. When combined with carcinogens during refeeding, this increased proliferative activity can actually increase carcinogenesis and/or pre-cancerous lesions in tissues including liver and colon (Tessitore et al., 1996). Although these studies underline the need for an in depth understanding of its mechanisms of action, fasting is expected to have cancer preventive effects as indicated by the studies above and by the findings that multiple cycles of periodic fasting can be as effective as toxic chemotherapy in the treatment of some cancers in mice (Lee et al., 2012).

In the treatment of cancer, fasting has been shown to have more consistent and positive effects. PF for 2–3 days was shown to protect mice from a variety of chemotherapy drugs, an effect called differential stress resistance (DSR) to reflect the inability of cancer cells to become protected based on the role of oncogenes in negatively regulating stress resistance, thus rendering cancer cells, by definition, unable to become protected in response to fasting conditions (Figure 5) (Raffaghello et al., 2008). PF also causes a major sensitization of various cancer cells to chemo-treatment, since it fosters an extreme environment in combination with the stress conditions caused by chemotherapy. In contrast to the protected state entered by normal cells during fasting, cancer cells are unable to adapt, a phenomenon called differential stress sensitization (DSS), based on the notion that most mutations are deleterious and that the many mutations accumulated in cancer cells promote growth under standard conditions but render them much less effective in adapting to extreme environments (Lee et al., 2012). In mouse models of metastatic tumors, combinations of fasting and chemotherapy that cause DSR and DSS, result in 20 to 60% cancer-free survival compared to the same levels of chemotherapy or fasting alone, which are not sufficient to cause any cancer-free survival (Lee et al., 2012;Shi et al., 2012). Thus, the idea that cancer could be treated with weeks of fasting alone, made popular decades ago, may be only partially true, at least for some type of cancers, but is expected to be ineffective for other types of cancers. The efficacy of long-term fasting alone (2 weeks or longer) in cancer treatment will need to be tested in carefully designed clinical trials in which side effects including malnourishment and possibly a weakened immune system and increased susceptibility to certain infections are carefully monitored. By contrast, animal data from multiple laboratories indicate that the combination of fasting cycles with chemotherapy is highly and consistently effective in enhancing chemotherapeutic index and has high translation potential. A number of ongoing trials should soon begin to determine the efficacy of fasting in enhancing cancer treatment in the clinic.

Figure 5

Differential stress resistance and sensitization in aging, disease prevention and cancer treatment

Fasting and neurodegeneration

Compared to ad libitum-fed controls, rats and mice maintained on an IF diet exhibit less neuronal dysfunction and degeneration, and fewer clinical symptoms in models of Alzheimer’s disease (AD), Parkinson’s disease (PD) and Huntington’s disease (HD). These models include transgenic mice expressing mutant human genes that cause dominantly inherited AD (amyloid precursor protein and presenilin-1) and frontotemporal lobe dementia (Tau) (Halagappa et al., 2007), PD (α-synuclein) (Griffioen et al., 2012) and HD (huntingtin) (Duan et al., 2003), as well as neurotoxin-based models pertinent to AD, PD and HD (Bruce-Keller et al., 1999; Duan and Mattson, 1999). Animals on an IF diet also fare better than ad libitum-fed controls after acute injury including severe epileptic seizures, stroke, and traumatic brain and spinal cord injuries (Arumugam et al., 2010; Bruce-Keller et al., 1999; Plunet et al., 2008).

Several interrelated cellular mechanisms contribute to the beneficial effects of IF on the nervous system including reduced accumulation of oxidatively damaged molecules, improved cellular bioenergetics, enhanced neurotrophic factor signaling, and reduced inflammation (Mattson, 2012a). The latter neuroprotective mechanisms are supported by studies showing that IF diets boost levels of antioxidant defenses, neurotrophic factors (BDNF and FGF2) and protein chaperones (HSP-70 and GRP-78), and reduce levels of pro-inflammatory cytokines (TNFα, IL-1β and IL-6) (Figure 4) (Arumugam et al., 2010). IF may also promote restoration of damaged nerve cell circuits by stimulating synapse formation and the production of new neurons from neural stem cells (neurogenesis) (Lee et al., 2002). Interestingly, while beneficial in models of most neurodegenerative conditions, there is evidence that fasting can hasten neurodegeneration in some models of inherited amyotrophic lateral sclerosis, perhaps because the motor neurons affected in those models are unable to respond adaptively to the moderate stress imposed by fasting (Mattson et al., 2007; Pedersen and Mattson, 1999).

Fasting and the metabolic syndrome

Metabolic syndrome (MS), defined as abdominal adiposity, combined with insulin resistance, elevated triglycerides and/or hypertension, greatly increases the risk of cardiovascular disease, diabetes, stroke and AD. Rats and mice maintained under the usual ad libitum feeding condition develop an MS-like phenotype as they age. MS can also be induced in younger animals by feeding them a diet high in fat and simple sugars (Martin et al., 2010). IF can prevent and reverse all aspects of the MS in rodents: abdominal fat, inflammation and blood pressure are reduced, insulin sensitivity is increased, and the functional capacities of the nervous, neuromuscular and cardiovascular systems are improved (Castello et al., 2010; Wan et al., 2003). Hyperglycemia is ameliorated by IF in rodent models of diabetes (Pedersen et al., 1999) and the heart is protected against ischemic injury in myocardial infarction models (Ahmet et al., 2005). A protective effect of fasting against ischemic renal and liver injury occurs rapidly, with 1 – 3 days of fasting improving functional outcome and reducing tissue injury and mortality (Mitchell et al., 2010). Six days on a diet missing just a single essential amino acid such as tryptophan can also elicit changes in metabolism and stress resistance, similar to those caused by fasting, which are dependent on the amino acid sensing kinase Gcn2 (Peng et al., 2012).

Multiple hormonal changes that typify MS in humans a re observed in rodents maintained on high fat and sugar diets including elevated levels of insulin and leptin and reduced levels of adiponectin and ghrelin. Elevated leptin levels are typically reflective of a pro-inflammatory state, whereas adiponectin and ghrelin can suppress inflammation and increase insulin sensitivity (Baatar et al., 2011; Yamauchi et al., 2001). Local inflammation in hypothalamic nuclei that control energy intake and expenditure may contribute to a sustained positive energy balance in MS (Milanski et al., 2012). Fasting results in a lowering of insulin and leptin levels and an elevation of adiponectin and ghrelin levels. By increasing insulin and leptin sensitivity, suppressing inflammation and stimulating autophagy, fasting reverses all the major abnormalities of the MS in rodents (Singh et al., 2009; Wan et al., 2010). Finally, in addition to its many effects on cells throughout the body and brain, IF may elicit changes in the gut microbiota that protect against MS (Tremaroli and Backhed, 2012). Naturally, the challenge of applying fasting-based interventions to treat MS in humans is a major one, as some obese individuals may have difficulties in following IF for long periods.

Go to:

Fasting, aging, and disease in humans

Fasting and factors implicated in aging

Clinical and epidemiological data are consistent wit h an ability of fasting to retard the aging process and associated diseases. Major factors implicated in aging whose generation are accelerated by gluttonous lifestyles and slowed by energy restriction in humans include: 1) oxidative damage to proteins, DNA and lipids; 2) inflammation; 3) accumulation of dysfunctional proteins and organelles; and 4) elevated glucose, insulin and IGF-I, although IGF-1decreases with aging and its severe deficiency can be associated with certain pathologies (Bishop et al., 2010; Fontana and Klein, 2007). Serum markers of oxidative damage and inflammation as well as clinical symptoms are reduced over a period of 2–4 weeks in asthma patients maintained on an alternate day fasting diet (Johnson et al., 2007). Similarly, when on a 2 days/week fasting diet overweight women at risk for breast cancer exhibited reduced oxidative stress and inflammation (Harvie et al., 2011) and elderly men exhibited reductions in body weight and body fat, and improved mood (Teng et al., 2011). Additional effects of fasting in human cells that can be considered as potentially ‘anti-aging’ are inhibition the mTOR pathway, stimulation of autophagy and ketogenesis (Harvie et al., 2011; Sengupta et al., 2010).

Among the major effects of fasting relevant to aging and diseases are changes in the levels of IGF-1, IGFBP1, glucose, and insulin. Fasting for 3 or more days causes a 30% or more decrease in circulating insulin and glucose, as well as rapid decline in the levels of insulin-like growth factor 1 (IGF-1), the major growth factor in mammals, which together with insulin is associated with accelerated aging and cancer (Fontana et al., 2010). In humans, five days of fasting causes an over 60% decrease in IGF-1and a 5-fold or higher increase in one of the principal IGF-1-inhibiting proteins: IGFBP1 (Thissen et al., 1994a). This effect of fasting on IGF-1is mostly due to protein restriction, and particularly to the restriction of essential amino acids, but is also supported by calorie restriction since the decrease in insulin levels during fasting promotes reduction in IGF-1(Thissen et al., 1994a). Notably, in humans, chronic calorie restriction does not lead to a decrease in IGF-1unless combined with protein restriction (Fontana et al., 2008).

IF can be achieved in with a minimal decrease in overall calorie intake if the refeeding period in which subjects overeat is considered. Thus, fasting cycles provide a much more feasible strategy to achieve the beneficial effects of CR, and possibly stronger effects, without the burden of chronic underfeeding and some of the potentially adverse effects associated with weight loss or very low BMIs. In fact, subjects who are moderately overweight (BMI of 25–30) in later life can have reduced overall mortality risk compared to subjects of normal weight (Flegal et al., 2013). Although these results may be affected by the presence of many existing or developing pathologies in the low weight control group, they underline the necessity to differentiate between young individuals and elderly individuals who may use CR or fasting to reduce weight or delay aging. Although extreme dietary interventions during old age may continue to protect from age-related diseases, they could have detrimental effects on the immune system and the ability to respond to certain infectious diseases, wounds and other challenges (Kristan, 2008; Reed et al., 1996). However, IF or PF designed to avoid weight loss and maximize nourishment have the potential to have beneficial effects on infectious diseases, wounds and other insults even in the very old. Nourishment of subjects can be achieved by complementing IF or PF with micro- and macro Studies to test the effect of IF or PF regimens on markers of aging, cancer, cognition and obesity are in progress (V. Longo and M. Mattson).

Fasting and cancer

Fasting has the potential for applications in both cancer prevention and treatment. Although no human data are available on the effect of IF or PF in cancer prevention, their effect on reducing IGF-1, insulin and glucose levels, and increasing IGFBP1 and ketone body levels could generate a protective environment that reduces DNA damage and carcinogenesis, while at the same time creating hostile conditions for tumor and pre-cancerous cells (Figure 5). In fact, elevated circulating IGF-1 is associated with increased risk of developing certain cancers (Chan et al., 2000; Giovannucci et al., 2000) and individuals with severe IGF-1deficiency caused by growth hormone receptor deficiency, rarely develop cancer (Guevara-Aguirre et al., 2011; Shevah and Laron, 2007; Steuerman et al., 2011). Furthermore, the serum from these IGF-1deficient subjects protected human epithelial cells from oxidative stress-induced DNA damage. Furthermore, once their DNA became damaged, cells were more likely to undergo programmed cell death (Guevara-Aguirre et al., 2011). Thus, fasting may protect from cancer by reducing cellular and DNA damage but also by enhancing the death of pre-cancerous cells.

In a preliminary study of 10 subjects with a variety of malignancies, the combination of chemotherapy with fasting resulted in a decrease in a range of self-reported common side effects caused by chemotherapy compared to the same subjects receiving chemotherapy while on a standard diet (Safdie et al., 2009). The effect of fasting on chemotherapy toxicity and cancer progression is now being tested in clinical trials in both Europe and the US (0S-08-9, 0S-10-3).

Fasting and neurodegeneration

Our current understanding of the impact of IF on the nervous system and cognitive functions is largely inferred from animal studies (see above). Interventional studies to determine the impact of fasting on brain function and neurodegenerative disease processes are lacking After 3–4 month, CR improved cognitive function (verbal memory) in overweight women (Kretsch et al., 1997) and in elderly subjects (Witte et al., 2009). Similarly, when subjects with mild cognitive impairment were maintained for 1 month on a low glycemic diet, they exhibited improved delayed visual memory, cerebrospinal fluid biomarkers of Aβ metabolism and brain bioenergetics (Bayer-Carter et al., 2011). Studies in which cognitive function, regional brain volumes, neural network activity, and biochemical analyses of cerebrospinal fluid are measured in human subjects before and during an extended period of IF should clarify the impact of IF on human brain structure and function.

Fasting, inflammation and hypertension

In humans, one of the best demonstrations of the beneficial effects of long-term fasting lasting one to 3 weeks is in the treatment of rheumatoid arthritis (RA). In agreement with the results in rodents, there is little doubt that during the period of fasting both inflammation and pain are reduced in RA patients (Muller et al., 2001). However, after the normal diet is resumed, inflammation returns unless the fasting period is followed by a vegetarian diet (Kjeldsen-Kragh et al., 1991), a combination therapy that has beneficial effects lasting for two years or longer (Kjeldsen-Kragh et al., 1994). The validity of this approach is supported by four differently controlled studies, including two randomized trials (Muller et al., 2001). Therefore, fasting combined with a vegetarian diet and possibly with other modified diets provides beneficial effects in the treatment of RA. Alternate day IF also resulted in significant reductions in serum TNFα and ceramides in asthma patients during a 2 month period (Johnson et al., 2007). The latter study further showed that markers of oxidative stress often associated with inflammation (protein and lipid oxidation) were significantly reduced in response to IF. Thus, for many patients able and willing to endure long-term fasting and to permanently modify their diet, fasting cycles would have the potential to not only augment but also replace existing medical treatments.

Water only and other forms of long-term fasting have also been documented to have potent effects on hypertension. An average of 13 days of water only fasting resulted in the achievement of a systolic blood pressure (BP) below 120 in 82% of subjects with borderline hypertension with a mean 20 mm Hg reduction in BP (Goldhamer et al., 2002). BP remained significantly lower compared to baseline even after subjects resumed the normal diet for an average of 6 days (Goldhamer et al., 2002). A small pilot study of patients with hypertension (140 mm and above systolic BP) also showed that 10–11 days of fasting caused a 37–60 mm decrease in systolic BP (Goldhamer et al., 2001). These preliminary studies are promising but underscore the need for larger controlled and randomized clinical studies that focus on periodic fasting strategies that are feasible for a larger portion of the population.

For both hypertension and RA it will be important to develop PF mimicking diets that are as effective as the fasting regimens described above but that are also tolerable by the great majority of patients.

Fasting and the metabolic syndrome

Periodic fasting can reverse multiple features of the metabolic syndrome in humans: it enhances insulin sensitivity, stimulates lipolysis and reduces blood pressure. Body fat and blood pressure were reduced and glucose metabolism improved in obese subjects in response to an alternate day modified fast (Klempel et al., 2013; Varady et al., 2009). Overweight subjects maintained for 6 months on a twice weekly IF diet in which they consumed only 500–600 calories on the fasting days, lost abdominal fat, displayed improved insulin sensitivity and reduced blood pressure (Harvie et al., 2011). Three weeks of alternate day fasting resulted in reductions in body fat and insulin levels in normal weight men and women (Heilbronn et al., 2005) and Ramadan fasting (2 meals/day separated by approximately 12 hours) in subjects with MS resulted in decreased daily energy intake, decreased plasma glucose levels and increased insulin sensitivity (Shariatpanahi et al., 2008). Subjects undergoing coronary angiography who reported that they fasted regularly exhibited a lower prevalence of diabetes compared to non-fasters (Horne et al., 2012). Anti-metabolic syndrome effects of IF were also observed in healthy young men (BMI of 25) after 15 days of alternate day fasting: their whole-body glucose uptake rates increased significantly, levels of plasma ketone bodies and adiponectin were elevated, all of which occurred without a significant decrease in body weight (Halberg et al., 2005). The latter findings are similar to data from animal studies showing that IF can improve glucose metabolism even with little or no weight change (Anson et al., 2003). It will be important to determine if longer fasting periods which promote a robust switch to a fat breakdown and ketone body-based metabolism, can cause longer lasting and more potent effects.

Conclusions and Recommendations

Based on the existing evidence from animal and human studies described, we conclude that there is great potential for lifestyles that incorporate periodic fasting during adult life to promote optimal health and reduce the risk of many chronic diseases, particularly for those who are overweight and sedentary. Animal studies have documented robust and replicable effects of fasting on health indicators including greater insulin sensitivity, and reduced levels of blood pressure, body fat, IGF-I, insulin, glucose, atherogenic lipids and inflammation. Fasting regimens can ameliorate disease processes and improve functional outcome in animal models of disorders that include myocardial infarction, diabetes, stroke, AD and PD. One general mechanism of action of fasting is that it triggers adaptive cellular stress responses, which result in an enhanced ability to cope with more severe stress and counteract disease processes. In addition, by protecting cells from DNA damage, suppressing cell growth and enhancing apoptosis of damaged cells, fasting could retard and/or prevent the formation and growth of cancers.

However, studies of fasting regimens have not been performed in children, the very old and underweight individuals, and it is possible that IF and PF would be harmful to these populations. Fasting periods lasting longer than 24 hours and particularly those lasting 3 or more days should be done under the supervision of a physician and preferably in a clinic. IF- and PF-based approaches towards combating the current epidemics of overweight, diabetes and related diseases should be pursued in human research studies and medical treatment plans. Several variations of potential ‘fasting prescriptions’ that have been adopted for overweight subjects revolve around the common theme of abstaining from food and caloric beverages for at least 12 – 24 hours on one or more days each week or month, depending on the length, combined with regular exercise. For those who are overweight, physicians could ask their patients to choose a fasting-based intervention that they believe they could comply with based upon their daily and weekly schedules. Examples include the ‘5:2’ IF diet (Harvie et al., 2011), the alternate day modified fasting diet (Johnson et al., 2007; Varady et al., 2009), a 4–5 day fast or low calorie but high nourishment fasting mimicking diets once every 1–3 months followed by the skipping of one major meal every day if needed (V. Longo, clinical trial in progress). One of the concerns with unbalanced alternating diets such as those in which low calorie intake is only observed for 2 days a week are the potential effects on circadian rhythm and the endocrine and gastrointestinal systems, which are known to be influenced by eating habits. During the first 4 – 6 weeks of implementation of the fasting regimen, a physician or registered dietitian should be in regular contact with the patient to monitor their progress and to provide advice and supervision.

Fasting regimens could also be tailored for specific diseases as stand-alone or adjunct therapies. Results of initial trials of IF (fasting 2 days per week or every other day) in human subjects suggest that there is a critical transition period of 3 – 6 weeks during which time the brain and body adapt to the new eating pattern and mood is enhanced (Harvie et al., 2011; Johnson et al., 2007). Though speculative, it is likely that during the latter transition period brain neurochemistry changes so that the ‘addiction’ to regular consumption of food throughout the day is overcome. Notably, the various fasting approaches are likely to have limited efficacy particularly on aging and conditions other than obesity unless combined with diets such as the moderate calorie intake and mostly plant-based Mediterranean or Okinawa low protein diets (0.8 g protein/Kg of body weight), consistently associated with health and longevity.

In the future, it will be important to combine epidemiological data, studies of long-lived populations and their diets, results from model organisms connecting specific dietary components to pro-aging and pro-disease factors, with data from studies on fasting regimens in humans, to design large clinical studies that integrate fasting with diets recognized as protective and enjoyable. A better understanding of the molecular mechanisms by which fasting affects various cell types and organ systems should lead to the development of novel prophylactic and therapeutic interventions for a wide range of disorders.

Go to:

Acknowledgments

We thank Min Wei for all the assistance with the preparation of the manuscript. We thank Yvon Le Maho for providing valuable information about fasting and a picture of penguins. We thank Matt Kaeberlein and Matthew Piper for panels for Figure 1. We thank William Mair for helpful discussions on fasting inDrosophila. This work was supported, in part, by the Intramural Research Program of the National Institute on Aging, by the Glenn Foundation for Medical Research, and by NIH/NIA grants AG20642, AG025135, and AG034906 to VDL.

Go to:

Footnotes

 

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

 

Go to:

References

• Adams SH, Costa DP. Water conservation and protein metabolism in northern elephant seal pups during the postweaning fast\ Journal of comparative physiology B, Biochemical, systemic, and environmental physiology. 1993;163:367–373. [PubMed]
• Ahmet I, Wan R, Mattson MP, Lakatta EG, Talan M. Cardioprotection by intermittent fasting in rats.Circulation. 2005;112:3115–3121. [PubMed]
• Anson RM, Guo Z, de Cabo R, Iyun T, Rios M, Hagepanos A, Ingram DK, Lane MA, Mattson MP. Intermittent fasting dissociates beneficial effects of dietary restriction on glucose metabolism and neuronal resistance to injury from calorie intake. Proc Natl Acad Sci U S A. 2003;100:6216–6220.[PMC free article] [PubMed]
• Arum O, Bonkowski MS, Rocha JS, Bartke A. The growth hormone receptor gene-disrupted mouse fails to respond to an intermittent fasting diet. Aging Cell. 2009;8:756–760. [PMC free article][PubMed]
• Arumugam TV, Phillips TM, Cheng A, Morrell CH, Mattson MP, Wan R. Age and energy intake interact to modify cell stress pathways and stroke outcome. Annals of neurology. 2010;67:41–52.[PMC free article] [PubMed]
• Atkinson SN, Ramsay MA. The Effects of Prolonged Fasting of the Body Composition and Reproductive Success of Female Polar Bears (Ursus maritimus) Functional Ecology. 1995;9
• Baatar D, Patel K, Taub DD. The effects of ghrelin on inflammation and the immune system. Mol Cell Endocrinol. 2011;340:44–58. [PubMed]
• Bayer-Carter JL, Green PS, Montine TJ, VanFossen B, Baker LD, Watson GS, Bonner LM, Callaghan M, Leverenz JB, Walter BK, Tsai E, Plymate SR, Postupna N, Wilkinson CW, Zhang J, Lampe J, Kahn SE, Craft S. Diet intervention and cerebrospinal fluid biomarkers in amnestic mild cognitive impairment. Arch Neurol. 2011;68:743–752. [PMC free article] [PubMed]
• Berrigan D, Perkins SN, Haines DC, Hursting SD. Adult-onset calorie restriction and fasting delay spontaneous tumorigenesis in p53-deficient mice. Carcinogenesis. 2002;23:817–822. [PubMed]
• Bishop NA, Lu T, Yankner BA. Neural mechanisms of ageing and cognitive decline. Nature.2010;464:529–535. [PMC free article] [PubMed]
• Bruce-Keller AJ, Umberger G, McFall R, Mattson MP. Food restriction reduces brain damage and improves behavioral outcome following excitotoxic and metabolic insults. Annals of neurology.1999;45:8–15. [PubMed]
• Cahill GF., Jr Fuel metabolism in starvation. Annu Rev Nutr. 2006;26:1–22. [PubMed]
• Carlson AJ, Hoelzel F. Apparent prolongation of the life span of rats by intermittent fasting. J Nutr.1946;31:363–375. [PubMed]
• Castellini MA, Rea LD. The biochemistry of natural fasting at its limits. Experientia. 1992;48:575–582. [PubMed]
• Castello L, Froio T, Maina M, Cavallini G, Biasi F, Leonarduzzi G, Donati A, Bergamini E, Poli G, Chiarpotto E. Alternate-day fasting protects the rat heart against age-induced inflammation and fibrosis by inhibiting oxidative damage and NF-kB activation. Free Radic Biol Med. 2010;48:47–54.[PubMed]
• Chan JM, Stampfer MJ, Giovannucci E, Ma J, Pollak M. Insulin-like growth factor I (IGF-I), IGF-binding protein-3 and prostate cancer risk: epidemiological studies. Growth Horm IGF Res.2000;10(Suppl A):S32–33. [PubMed]
• Chao MV. Trophic factors: An evolutionary cul-de-sac or door into higher neuronal function? Journal of neuroscience research. 2000;59:353–355. [PubMed]
• Cherel Y, Attaix D, Rosolowska-Huszcz D, Belkhou R, Robin JP, Arnal M, Le Maho Y. Whole-body and tissue protein synthesis during brief and prolonged fasting in the rat. Clin Sci (Lond)1991;81:611–619. [PubMed]
• Cherel Y, Groscolas R. Relationships between nutrient storage and nutrient utilisation in long-term fasting birds and mammals. In: Adams Durban NJ, Slotow RH., editors. Proc 22 Int Ornithol Congr.Johannesburg: BirdLife South Africa; 1999. pp. 17–34.
• Cherel Y, Le Maho Y. Five months of fasting in king penguin chicks: body mass loss and fuel metabolism. Am J Physiol. 1985;249:R387–392. [PubMed]
• Cherel Y, Leloup J, Le Maho Y. Fasting in king penguin. II. Hormonal and metabolic changes during molt. Am J Physiol. 1988a;254:R178–184. [PubMed]
• Cherel Y, Robin JP, Walch O, Karmann H, Netchitailo P, Le Maho Y. Fasting in king penguin. I. Hormonal and metabolic changes during breeding. Am J Physiol. 1988b;254:R170–177. [PubMed]
• Descamps O, Riondel J, Ducros V, Roussel AM. Mitochondrial production of reactive oxygen species and incidence of age-associated lymphoma in OF1 mice: effect of alternate-day fasting. Mech Ageing Dev. 2005;126:1185–1191. [PubMed]
• Duan W, Guo Z, Jiang H, Ware M, Li XJ, Mattson MP. Dietary restriction normalizes glucose metabolism and BDNF levels, slows disease progression, and increases survival in huntingtin mutant mice. Proc Natl Acad Sci U S A. 2003;100:2911–2916. [PMC free article] [PubMed]
• Duan W, Mattson MP. Dietary restriction and 2-deoxyglucose administration improve behavioral outcome and reduce degeneration of dopaminergic neurons in models of Parkinson’s disease. Journal of neuroscience research. 1999;57:195–206. [PubMed]
• Eichhorn G, Groscolas R, Le Glaunec G, Parisel C, Arnold L, Medina P, Handrich Y. Heterothermy in growing king penguins. Nat Commun. 2011;2:435. [PubMed]
• Fabrizio P, Gattazzo C, Battistella L, Wei M, Cheng C, McGrew K, Longo VD. Sir2 blocks extreme life-span extension. Cell. 2005;123:655–667. [PubMed]
• Favier RJ, Koubi HE. Metabolic and structural adaptations to exercise in chronic intermittent fasted rats. Am J Physiol. 1988;254:R877–884. [PubMed]
• Flegal KM, Kit BK, Orpana H, Graubard BI. Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis. JAMA.2013;309:71–82. [PubMed]
• Fond G, Macgregor A, Leboyer M, Michalsen A. Fasting in mood disorders: neurobiology and effectiveness. A review of the literature. Psychiatry research 2013 [PubMed]
• Fontan-Lozano A, Saez-Cassanelli JL, Inda MC, de los Santos-Arteaga M, Sierra-Dominguez SA, Lopez-Lluch G, Delgado-Garcia JM, Carrion AM. Caloric restriction increases learning consolidation and facilitates synaptic plasticity through mechanisms dependent on NR2B subunits of the NMDA receptor. J Neurosci. 2007;27:10185–10195. [PubMed]
• Fontana L, Klein S. Aging, adiposity, and calorie restriction. JAMA. 2007;297:986–994. [PubMed]
• Fontana L, Partridge L, Longo VD. Extending healthy life span--from yeast to humans. Science.2010;328:321–326. [PMC free article] [PubMed]
• Fontana L, Weiss EP, Villareal DT, Klein S, Holloszy JO. Long-term effects of calorie or protein restriction on serum IGF-1 and IGFBP-3 concentration in humans. Aging Cell. 2008;7:681–687.[PMC free article] [PubMed]
• Giovannucci E, Pollak M, Platz EA, Willett WC, Stampfer MJ, Majeed N, Colditz GA, Speizer FE, Hankinson SE. Insulin-like growth factor I (IGF-I), IGF-binding protein-3 and the risk of colorectal adenoma and cancer in the Nurses’ Health Study. Growth Horm IGF Res. 2000;10(Suppl A):S30–31.[PubMed]
• Goldhamer A, Lisle D, Parpia B, Anderson SV, Campbell TC. Medically supervised water-only fasting in the treatment of hypertension. Journal of manipulative and physiological therapeutics.2001;24:335–339. [PubMed]
• Goldhamer AC, Lisle DJ, Sultana P, Anderson SV, Parpia B, Hughes B, Campbell TC. Medically supervised water-only fasting in the treatment of borderline hypertension. J Altern Complement Med.2002;8:643–650. [PubMed]
• Gonidakis S, Finkel SE, Longo VD. Genome-wide screen identifies Escherichia coli TCA-cycle-related mutants with extended chronological lifespan dependent on acetate metabolism and the hypoxia-inducible transcription factor ArcA. Aging Cell. 2010;9:868–881. [PMC free article][PubMed]
• Goodrick CL, Ingram DK, Reynolds MA, Freeman JR, Cider N. Effects of intermittent feeding upon body weight and lifespan in inbred mice: interaction of genotype and age. Mech Ageing Dev.1990;55:69–87. [PubMed]
• Grandison RC, Wong R, Bass TM, Partridge L, Piper MD. Effect of a standardised dietary restriction protocol on multiple laboratory strains of Drosophila melanogaster. PLoS One. 2009;4:e4067.[PMC free article] [PubMed]
• Greer EL, Dowlatshahi D, Banko MR, Villen J, Hoang K, Blanchard D, Gygi SP, Brunet A. An AMPK-FOXO pathway mediates longevity induced by a novel method of dietary restriction in C. elegans. Curr Biol. 2007;17:1646–1656. [PMC free article] [PubMed]
• Griffioen KJ, Wan R, Brown TR, Okun E, Camandola S, Mughal MR, Phillips TM, Mattson MP. Aberrant heart rate and brainstem brain-derived neurotrophic factor (BDNF) signaling in a mouse model of Huntington’s disease. Neurobiol Aging. 2012;33:1481–e1481. 1485. [PMC free article][PubMed]
• Guevara-Aguirre J, Balasubramanian P, Guevara-Aguirre M, Wei M, Madia F, Cheng CW, Hwang D, Martin-Montalvo A, Saavedra J, Ingles S, de Cabo R, Cohen P, Longo VD. Growth hormone receptor deficiency is associated with a major reduction in pro-aging signaling, cancer, and diabetes in humans. Sci Transl Med. 2011;3:70ra13. [PMC free article] [PubMed]
• Halagappa VK, Guo Z, Pearson M, Matsuoka Y, Cutler RG, Laferla FM, Mattson MP. Intermittent fasting and caloric restriction ameliorate age-related behavioral deficits in the triple-transgenic mouse model of Alzheimer’s disease. Neurobiology of disease. 2007;26:212–220. [PubMed]
• Halberg N, Henriksen M, Soderhamn N, Stallknecht B, Ploug T, Schjerling P, Dela F. Effect of intermittent fasting and refeeding on insulin action in healthy men. J Appl Physiol. 2005;99:2128–2136. [PubMed]
• Hartman AL, Rubenstein JE, Kossoff EH. Intermittent fasting: A “new” historical strategy for controlling seizures? Epilepsy research 2012 [PMC free article] [PubMed]
• Harvie MN, Pegington M, Mattson MP, Frystyk J, Dillon B, Evans G, Cuzick J, Jebb SA, Martin B, Cutler RG, Son TG, Maudsley S, Carlson OD, Egan JM, Flyvbjerg A, Howell A. The effects of intermittent or continuous energy restriction on weight loss and metabolic disease risk markers: a randomized trial in young overweight women. Int J Obes (Lond) 2011;35:714–727. [PMC free article][PubMed]
• Heilbronn LK, Smith SR, Martin CK, Anton SD, Ravussin E. Alternate-day fasting in nonobese subjects: effects on body weight, body composition, and energy metabolism. Am J Clin Nutr.2005;81:69–73. [PubMed]
• Honjoh S, Yamamoto T, Uno M, Nishida E. Signalling through RHEB-1 mediates intermittent fasting-induced longevity in C. elegans. Nature. 2009;457:726–730. [PubMed]
• Horne BD, Muhlestein JB, May HT, Carlquist JF, Lappe DL, Bair TL, Anderson JL. Relation of routine, periodic fasting to risk of diabetes mellitus, and coronary artery disease in patients undergoing coronary angiography. Am J Cardiol. 2012;109:1558–1562. [PubMed]
• Johnson JB, Summer W, Cutler RG, Martin B, Hyun DH, Dixit VD, Pearson M, Nassar M, Telljohann R, Maudsley S, Carlson O, John S, Laub DR, Mattson MP. Alternate day calorie restriction improves clinical findings and reduces markers of oxidative stress and inflammation in overweight adults with moderate asthma. Free Radic Biol Med. 2007;42:665–674. [PMC free article][PubMed]
• Kaeberlein TL, Smith ED, Tsuchiya M, Welton KL, Thomas JH, Fields S, Kennedy BK, Kaeberlein M. Lifespan extension in Caenorhabditis elegans by complete removal of food. Aging Cell.2006;5:487–494. [PubMed]
• Kashiwaya Y, Bergman C, Lee JH, Wan R, Todd King M, Mughal MR, Okun E, Clarke K, Mattson MP, Veech RL. A ketone ester diet exhibits anxiolytic and cognition-sparing properties, and lessens amyloid and tau pathologies in a mouse model of Alzheimer’s disease. Neurobiol Aging 2012[PMC free article] [PubMed]
• Kendrick DC. The effects of infantile stimulation and intermittent fasting and feeding on life span in the black-hooded rat. Developmental psychobiology. 1973;6:225–234. [PubMed]
• Kjeldsen-Kragh J, Haugen M, Borchgrevink CF, Forre O. Vegetarian diet for patients with rheumatoid arthritis--status: two years after introduction of the diet. Clinical rheumatology.1994;13:475–482. [PubMed]
• Kjeldsen-Kragh J, Haugen M, Borchgrevink CF, Laerum E, Eek M, Mowinkel P, Hovi K, Forre O. Controlled trial of fasting and one-year vegetarian diet in rheumatoid arthritis. Lancet. 1991;338:899–902. [PubMed]
• Klempel MC, Kroeger CM, Varady KA. Alternate day fasting (ADF) with a high-fat diet produces similar weight loss and cardio-protection as ADF with a low-fat diet. Metabolism: clinical and experimental. 2013;62:137–143. [PubMed]
• Kretsch MJ, Green MW, Fong AK, Elliman NA, Johnson HL. Cognitive effects of a long-term weight reducing diet. International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity. 1997;21:14–21. [PubMed]
• Kristan DM. Calorie restriction and susceptibility to intact pathogens. Age (Dordr) 2008;30:147–156.[PMC free article] [PubMed]
• Le Maho Y, Delclitte P, Chatonnet J. Thermoregulation in fasting emperor penguins under natural conditions. Am J Physiol. 1976;231:913–922. [PubMed]
• Le Maho Y, Vu Van Kha H, Koubi H, Dewasmes G, Girard J, Ferre P, Cagnard M. Body composition, energy expenditure, and plasma metabolites in long-term fasting geese. Am J Physiol.1981;241:E342–354. [PubMed]
• Lee C, Raffaghello L, Brandhorst S, Safdie FM, Bianchi G, Martin-Montalvo A, Pistoia V, Wei M, Hwang S, Merlino A, Emionite L, de Cabo R, Longo VD. Fasting cycles retard growth of tumors and sensitize a range of cancer cell types to chemotherapy. Sci Transl Med. 2012;4:124ra127.[PMC free article] [PubMed]
• Lee C, Safdie FM, Raffaghello L, Wei M, Madia F, Parrella E, Hwang D, Cohen P, Bianchi G, Longo VD. Reduced levels of IGF-I mediate differential protection of normal and cancer cells in response to fasting and improve chemotherapeutic index. Cancer Res. 2010;70:1564–1572.[PMC free article] [PubMed]
• Lee GD, Wilson MA, Zhu M, Wolkow CA, de Cabo R, Ingram DK, Zou S. Dietary deprivation extends lifespan in Caenorhabditis elegans. Aging Cell. 2006;5:515–524. [PMC free article] [PubMed]
• Lee J, Seroogy KB, Mattson MP. Dietary restriction enhances neurotrophin expression and neurogenesis in the hippocampus of adult mice. J Neurochem. 2002;80:539–547. [PubMed]
• Longo VD, Ellerby LM, Bredesen DE, Valentine JS, Gralla EB. Human Bcl-2 reverses survival defects in yeast lacking superoxide dismutase and delays death of wild-type yeast. J Cell Biol.1997;137:1581–1588. [PMC free article] [PubMed]
• Longo VD, Shadel GS, Kaeberlein M, Kennedy B. Replicative and chronological aging in Saccharomyces cerevisiae. Cell Metab. 2012;16:18–31. [PMC free article] [PubMed]
• Mager DE, Wan R, Brown M, Cheng A, Wareski P, Abernethy DR, Mattson MP. Caloric restriction and intermittent fasting alter spectral measures of heart rate and blood pressure variability in rats.FASEB J. 2006;20:631–637. [PubMed]
• Martin B, Ji S, Maudsley S, Mattson MP. “Control” laboratory rodents are metabolically morbid: why it matters. Proc Natl Acad Sci U S A. 2010;107:6127–6133. [PMC free article] [PubMed]
• Masoro EJ. Overview of caloric restriction and ageing. Mech Ageing Dev. 2005;126:913–922.[PubMed]
• Mattson MP. Energy intake and exercise as determinants of brain health and vulnerability to injury and disease. Cell Metab. 2012a;16:706–722. [PMC free article] [PubMed]
• Mattson MP. Evolutionary aspects of human exercise--born to run purposefully. Ageing Res Rev.2012b;11:347–352. [PMC free article] [PubMed]
• Mattson MP, Cutler RG, Camandola S. Energy intake and amyotrophic lateral sclerosis.Neuromolecular medicine. 2007;9:17–20. [PubMed]
• Milanski M, Arruda AP, Coope A, Ignacio-Souza LM, Nunez CE, Roman EA, Romanatto T, Pascoal LB, Caricilli AM, Torsoni MA, Prada PO, Saad MJ, Velloso LA. Inhibition of hypothalamic inflammation reverses diet-induced insulin resistance in the liver. Diabetes. 2012;61:1455–1462.[PMC free article] [PubMed]
• Mitchell JR, Verweij M, Brand K, van de Ven M, Goemaere N, van den Engel S, Chu T, Forrer F, Muller C, de Jong M, van IW, JNIJ, Hoeijmakers JH, de Bruin RW. Short-term dietary restriction and fasting precondition against ischemia reperfusion injury in mice. Aging Cell. 2010;9:40–53.[PMC free article] [PubMed]
• Muller H, de Toledo FW, Resch KL. Fasting followed by vegetarian diet in patients with rheumatoid arthritis: a systematic review. Scandinavian journal of rheumatology. 2001;30:1–10. [PubMed]
• Pedersen CR, Hagemann I, Bock T, Buschard K. Intermittent feeding and fasting reduces diabetes incidence in BB rats. Autoimmunity. 1999;30:243–250. [PubMed]
• Pedersen WA, Mattson MP. No benefit of dietary restriction on disease onset or progression in amyotrophic lateral sclerosis Cu/Zn-superoxide dismutase mutant mice. Brain Res. 1999;833:117–120.[PubMed]
• Peng W, Robertson L, Gallinetti J, Mejia P, Vose S, Charlip A, Chu T, Mitchell JR. Surgical stress resistance induced by single amino acid deprivation requires Gcn2 in mice. Sci Transl Med.2012;4:118ra111. [PMC free article] [PubMed]
• Piper MD, Partridge L. Dietary restriction in Drosophila: delayed aging or experimental artefact? PLoS Genet. 2007;3:e57. [PMC free article] [PubMed]
• Plunet WT, Streijger F, Lam CK, Lee JH, Liu J, Tetzlaff W. Dietary restriction started after spinal cord injury improves functional recovery. Exp Neurol. 2008;213:28–35. [PubMed]
• Raffaghello L, Lee C, Safdie FM, Wei M, Madia F, Bianchi G, Longo VD. Starvation-dependent differential stress resistance protects normal but not cancer cells against high-dose chemotherapy. Proc Natl Acad Sci U S A. 2008;105:8215–8220. [PMC free article] [PubMed]
• Reed MJ, Penn PE, Li Y, Birnbaum R, Vernon RB, Johnson TS, Pendergrass WR, Sage EH, Abrass IB, Wolf NS. Enhanced cell proliferation and biosynthesis mediate improved wound repair in refed, caloric-restricted mice. Mech Ageing Dev. 1996;89:21–43. [PubMed]
• Reilly JJ. Adaptations to prolonged fasting in free-living weaned gray seal pups. Am J Physiol.1991;260:R267–272. [PubMed]
• Robin JP, Cherel Y, Girard H, Geloen A, Le Maho Y. Uric acid and urea in relation to protein catabolism in long-term fasting geese. Journal of comparative physiology B, Biochemical, systemic, and environmental physiology. 1987;157:491–499. [PubMed]
• Robin JP, Frain M, Sardet C, Groscolas R, Le Maho Y. Protein and lipid utilization during long-term fasting in emperor penguins. Am J Physiol. 1988;254:R61–68. [PubMed]
• Rothman SM, Griffioen KJ, Wan R, Mattson MP. Brain-derived neurotrophic factor as a regulator of systemic and brain energy metabolism and cardiovascular health. Ann N Y Acad Sci. 2012;1264:49–63. [PMC free article] [PubMed]
• Safdie FM, Dorff T, Quinn D, Fontana L, Wei M, Lee C, Cohen P, Longo VD. Fasting and cancer treatment in humans: A case series report. Aging (Albany NY) 2009;1:988–1007. [PMC free article][PubMed]
• Sakamoto K, Grunewald KK. Beneficial effects of exercise on growth of rats during intermittent fasting. J Nutr. 1987;117:390–395. [PubMed]
• Sengupta S, Peterson TR, Laplante M, Oh S, Sabatini DM. mTORC1 controls fasting-induced ketogenesis and its modulation by ageing. Nature. 2010;468:1100–1104. [PubMed]
• Shariatpanahi ZV, Shariatpanahi MV, Shahbazi S, Hossaini A, Abadi A. Effect of Ramadan fasting on some indices of insulin resistance and components of the metabolic syndrome in healthy male adults. The British journal of nutrition. 2008;100:147–151. [PubMed]
• Shevah O, Laron Z. Patients with congenital deficiency of IGF-I seem protected from the development of malignancies: a preliminary report. Growth Horm IGF Res. 2007;17:54–57. [PubMed]
• Shi Y, Felley-Bosco E, Marti TM, Orlowski K, Pruschy M, Stahel RA. Starvation-induced activation of ATM/Chk2/p53 signaling sensitizes cancer cells to cisplatin. BMC Cancer. 2012;12:571.[PMC free article] [PubMed]
• Singh R, Kaushik S, Wang Y, Xiang Y, Novak I, Komatsu M, Tanaka K, Cuervo AM, Czaja MJ. Autophagy regulates lipid metabolism. Nature. 2009;458:1131–1135. [PMC free article] [PubMed]
• Singh R, Lakhanpal D, Kumar S, Sharma S, Kataria H, Kaur M, Kaur G. Late-onset intermittent fasting dietary restriction as a potential intervention to retard age-associated brain function impairments in male rats. Age (Dordr) 2012;34:917–933. [PMC free article] [PubMed]
• Steuerman R, Shevah O, Laron Z. Congenital IGF1 deficiency tends to confer protection against post-natal development of malignancies. Eur J Endocrinol. 2011;164:485–489. [PubMed]
• Stranahan AM, Mattson MP. Recruiting adaptive cellular stress responses for successful brain ageing.Nat Rev Neurosci. 2012;13:209–216. [PMC free article] [PubMed]
• Teng NI, Shahar S, Manaf ZA, Das SK, Taha CS, Ngah WZ. Efficacy of fasting calorie restriction on quality of life among aging men. Physiology & behavior. 2011;104:1059–1064. [PubMed]
• Tessitore L, Tomasi C, Greco M, Sesca E, Laconi E, Maccioni O, Ramo R, Pani P. A subnecrogenic dose of diethylnitrosamine is able to initiate hepatocarcinogenesis in the rat when coupled with fasting/refeeding. Carcinogenesis. 1996;17:289–292. [PubMed]
• Thissen JP, Ketelslegers JM, Underwood LE. Nutritional regulation of the insulin-like growth factors.Endocr Rev. 1994a;15:80–101. [PubMed]
• Thissen JP, Pucilowska JB, Underwood LE. Differential regulation of insulin-like growth factor I (IGF-I) and IGF binding protein-1 messenger ribonucleic acids by amino acid availability and growth hormone in rat hepatocyte primary culture. Endocrinology. 1994b;134:1570–1576. [PubMed]
• Tremaroli V, Backhed F. Functional interactions between the gut microbiota and host metabolism.Nature. 2012;489:242–249. [PubMed]
• Varady KA, Bhutani S, Church EC, Klempel MC. Short-term modified alternate-day fasting: a novel dietary strategy for weight loss and cardioprotection in obese adults. Am J Clin Nutr. 2009;90:1138–1143. [PubMed]
• Varady KA, Hellerstein MK. Alternate-day fasting and chronic disease prevention: a review of human and animal trials. Am J Clin Nutr. 2007;86:7–13. [PubMed]
• Wan R, Ahmet I, Brown M, Cheng A, Kamimura N, Talan M, Mattson MP. Cardioprotective effect of intermittent fasting is associated with an elevation of adiponectin levels in rats. J Nutr Biochem.2010;21:413–417. [PMC free article] [PubMed]
• Wan R, Camandola S, Mattson MP. Intermittent fasting and dietary supplementation with 2-deoxy-D-glucose improve functional and metabolic cardiovascular risk factors in rats. FASEB J. 2003;17:1133–1134. [PubMed]
• Wei M, Fabrizio P, Hu J, Ge H, Cheng C, Li L, Longo VD. Life span extension by calorie restriction depends on Rim15 and transcription factors downstream of Ras/PKA, Tor, and Sch9. PLoS Genet.2008;4:e13. [PMC free article] [PubMed]
• Wei M, Fabrizio P, Madia F, Hu J, Ge H, Li LM, Longo VD. Tor1/Sch9-regulated carbon source substitution is as effective as calorie restriction in life span extension. PLoS Genet. 2009;5:e1000467.[PMC free article] [PubMed]
• Weindruch R, Sohal RS. Seminars in medicine of the Beth Israel Deaconess Medical Center. Caloric intake and aging. N Engl J Med. 1997;337:986–994. [PMC free article] [PubMed]
• Weindruch R, Walford RL. The retardation of aging and disease by dietary restriction. Springfield, Ill., U.S.A: C.C. Thomas; 1988.
• Witte AV, Fobker M, Gellner R, Knecht S, Floel A. Caloric restriction improves memory in elderly humans. Proc Natl Acad Sci U S A. 2009;106:1255–1260. [PMC free article] [PubMed]
• Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, Mori Y, Ide T, Murakami K, Tsuboyama-Kasaoka N, Ezaki O, Akanuma Y, Gavrilova O, Vinson C, Reitman ML, Kagechika H, Shudo K, Yoda M, Nakano Y, Tobe K, Nagai R, Kimura S, Tomita M, Froguel P, Kadowaki T. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med. 2001;7:941–946. [PubMed]

[planeta 5553]

http://news.yale.edu/2015/02/16/anti-inflammatory-mechanism-dieting-and-fasting-revealed

 

 

Anti-inflammatory mechanism of dieting and fasting revealed

By Karen N. Peart

February 16, 2015

Researchers at Yale School of Medicine have found that a compound produced by the body when dieting or fasting can block a part of the immune system involved in several inflammatory disorders such as type 2 diabetes, atherosclerosis, and Alzheimer’s disease.

In their study, published in the Feb. 16 online issue of Nature Medicine, the researchers described how the compound β-hydroxybutyrate (BHB) directly inhibits NLRP3, which is part of a complex set of proteins called the inflammasome. The inflammasome drives the inflammatory response in several disorders including autoimmune diseases, type 2 diabetes, Alzheimer’s disease, atherosclerosis, and autoinflammatory disorders.

“These findings are important because endogenous metabolites like BHB that block the NLRP3 inflammasome could be relevant against many inflammatory diseases, including those where there are mutations in the NLRP3 genes,” said Vishwa Deep Dixit, professor in the Section of Comparative Medicine at Yale School of Medicine.

BHB is a metabolite produced by the body in response to fasting, high-intensity exercise, caloric restriction, or consumption of the low-carbohydrate ketogenic diet. Dixit said it is well known that fasting and calorie restriction reduces inflammation in the body, but it was unclear how immune cells adapt to reduced availability of glucose and if they can respond to metabolites produced from fat oxidation.

Working with mice and human immune cells, Dixit and colleagues focused on how macrophages — specialized immune cells that produce inflammation — respond when exposed to ketone bodies and whether that impacts the inflammasone complex.

The team introduced BHB to mouse models of inflammatory diseases caused by NLP3. They found that this reduced inflammation, and that inflammation was also reduced when the mice were given a ketogenic diet, which elevates the levels of BHB in the bloodstream.

“Our results suggest that the endogenous metabolites like BHB that are produced during low-carb dieting, fasting, or high-intensity exercise can lower the NLRP3 inflammasome,” said Dixit.

Other authors on the study include Yun-Hee Youm, Kim Y. Nguyen, Ryan W Grant, Emily L. Goldberg, Monica Bodogai, Dongin Kim, Dominic D’Agostino, Noah Planavsky, Christopher Lupfer, Thirumala D Kanneganti, Seokwon Kang,
Tamas L. Horvath, Tarek M. Fahmy, Peter A. Crawford, Arya Biragyn, and Emad Alnemri.

The research was funded in part by National Institutes of Health grants AI105097, AGO43608, AG031797, and DK090556.

Citation: Nature Medicine DOI: 10.1038/nm.3804


[Peter8624 265]

Galera, no livro ele indica fazer jejuns de 24h por 2 dias na semana. Tem algum problema se for mais dias? Comecei a fazer esse tipo de jejum e não sinto vontade de comer durante o dia todo. É realmente incrível quando ele diz que a gente nunca sentiu realmente fome na vida, que para isso seria preciso passar mais de uma semana sem comer e tal.

[planeta 5553]

1 hora atrás, Peter8624 disse:

Galera, no livro ele indica fazer jejuns de 24h por 2 dias na semana. Tem algum problema se for mais dias? Comecei a fazer esse tipo de jejum e não sinto vontade de comer durante o dia todo. É realmente incrível quando ele diz que a gente nunca sentiu realmente fome na vida, que para isso seria preciso passar mais de uma semana sem comer e tal.

não tem problema, pode fazer maior que 24hs tb

 

se vc quiser só jantar todos os dias vai dar tipo 23 horas de jejum por dia e não vai fazer mal nenhum

[lucasf21 1673]

muzzy falou a respeito do jejum, falou que ao em vez de ganhar massa magra vai fazer a pessoa perder massa magra e ganhar gordura, quem quiser ver a live da max foi gravada, eae o que acham ? 

 

 

 

 

[Torf 11507]

8 horas atrás, lucasf21 disse:

muzzy falou a respeito do jejum, falou que ao em vez de ganhar massa magra vai fazer a pessoa perder massa magra e ganhar gordura, quem quiser ver a live da max foi gravada, eae o que acham ? 

 

 

 

 

Quase 6 horas de vídeo... Em que altura ele fala isso?

[lucasf21 1673]

3 horas atrás, Torf disse:

Quase 6 horas de vídeo... Em que altura ele fala isso?

Vish, parece que o vídeo saiu de ar, era entre 10/15 minutos.

Ele disse que não é uma boa opção, e que e mais fácil colocar um gordo pra fazer jejum e dar 4 horas pra ele comer, do que dar várias refeições no dia.

disse também que um gordo de 130 perder 10kg em jejum, 6kg disso vai ser massa magra, então pro gordo não faria diferença, pois o mesmo já é obeso.

[Lucas Vilela 26]

1 hora atrás, lucasf21 disse:

disse também que um gordo de 130 perder 10kg em jejum, 6kg disso vai ser massa magra

 

MEsmo se a pessoa esteja saciando todas as necessidades nutricionais ela vai acabar perdendo massa muscular em jejum que nem no caso do gordo de 130kg?

[lucasf21 1673]

Agora, Lucas Vilela disse:

 

MEsmo se a pessoa esteja saciando todas as necessidades nutricionais ela vai acabar perdendo massa muscular em jejum que nem no caso do gordo de 130kg?

Sim.

 não é só o muzzy que fala isso, vários e vários caras renomados falam, dennis james é um deles, só não falo isso no tópico pra não me apedrejarem.

 o muzzy disse que qualquer um que faça jejum vai catabolizar, segundo ele uma mulher fez um estudo, colocou dois grupos em jejum, um fez aeróbico em jejum em baixa intensidade, o outro treinou em jejum, o grupo que treinou em jejum ganhou gordura e perdeu massa muscular, o grupo que fez o aeróbico em jejum perdeu mais gordura ao longo do dia.

Resumindo: vários e vários profissionais e coach's renomados não são a favor do jejum.